ES443421A1 - 11-deoxy-15-substituted-16,17,18,19,20-pentanorprostaglandins - Google Patents
11-deoxy-15-substituted-16,17,18,19,20-pentanorprostaglandinsInfo
- Publication number
- ES443421A1 ES443421A1 ES443421A ES443421A ES443421A1 ES 443421 A1 ES443421 A1 ES 443421A1 ES 443421 A ES443421 A ES 443421A ES 443421 A ES443421 A ES 443421A ES 443421 A1 ES443421 A1 ES 443421A1
- Authority
- ES
- Spain
- Prior art keywords
- phenyl
- beta
- alpha
- thienyl
- substituent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- -1 beta-naphthyl Chemical group 0.000 abstract 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 5
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 125000001424 substituent group Chemical group 0.000 abstract 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 abstract 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract 2
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 abstract 2
- 229910052794 bromium Inorganic materials 0.000 abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- 229910052801 chlorine Inorganic materials 0.000 abstract 2
- 239000000460 chlorine Substances 0.000 abstract 2
- 229910052731 fluorine Inorganic materials 0.000 abstract 2
- 239000011737 fluorine Substances 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 125000003762 3,4-dimethoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C(OC([H])([H])[H])C([H])=C1* 0.000 abstract 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 125000001246 bromo group Chemical group Br* 0.000 abstract 1
- DMLFJMQTNDSRFU-UHFFFAOYSA-N chlordiazepoxide hydrochloride Chemical compound Cl.O=N=1CC(NC)=NC2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 DMLFJMQTNDSRFU-UHFFFAOYSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 125000000468 ketone group Chemical group 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 239000008196 pharmacological composition Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
- C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C61/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C61/06—Saturated compounds having a carboxyl group bound to a five-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/74—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1896—Compounds having one or more Si-O-acyl linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4056—Esters of arylalkanephosphonic acids
- C07F9/4059—Compounds containing the structure (RY)2P(=X)-(CH2)n-C(=O)-(CH2)m-Ar, (X, Y = O, S, Se; n>=1, m>=0)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Emergency Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Crystallography & Structural Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
A method of preparing a pharmacological composition containing an 11-deoxy-omega-pentanorprostaglandin having, at the 15-position, a hydroxyl or keto group and a substituent of the formula: ** (See formula) ** wherein: Ar is alpha- or beta-thienyl; 5-phenyl-alpha- or beta-thienyl; 5-lower alkyl-alpha- or beta-thienyl; alpha- or beta-naphthyl; tropium, phenyl; 3,4-dimethoxyphenyl; 3,4-methylenedioxyphenyl; 3,4-bichlorophenyl; 3,5-dimethylphenyl and monosubstituted phenyl, in which the substituent is bromine, chlorine, fluorine, trifluoromethyl, phenyl, lower alkyl or lower alkoxy; R is hydrogen or methyl and their C1 esters, in which the esterifying group is: an alkyl of 1 to 10 carbon atoms; an aralkyl of 7 to 9 carbon atoms; alpha- or beta-naphthyl; phenyl or substituted phenyl, in which the substituent is lower alkyl, lower alkoxy, chlorine, bromine, fluorine or phenyl, characterized by preparing said compound by chemical methods that are used in the chemistry of progtaglaadines, purifying until reaching a norm pharmaceutical and, if necessary, combined with a carrier vehicle. (Machine-translation by Google Translate, not legally binding)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US53167674A | 1974-11-11 | 1974-11-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES443421A1 true ES443421A1 (en) | 1977-04-16 |
Family
ID=24118594
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES443421A Expired ES443421A1 (en) | 1974-12-11 | 1975-12-11 | 11-deoxy-15-substituted-16,17,18,19,20-pentanorprostaglandins |
Country Status (22)
Country | Link |
---|---|
JP (3) | JPS51125257A (en) |
AT (1) | AT351185B (en) |
BE (1) | BE836564A (en) |
BG (1) | BG27227A3 (en) |
CH (1) | CH610302A5 (en) |
CS (3) | CS194733B2 (en) |
DD (3) | DD129783A5 (en) |
DE (1) | DE2555210A1 (en) |
DK (1) | DK559975A (en) |
ES (1) | ES443421A1 (en) |
FI (1) | FI753475A (en) |
FR (1) | FR2293923A1 (en) |
GB (3) | GB1508168A (en) |
GR (1) | GR60310B (en) |
IE (1) | IE43815B1 (en) |
IL (2) | IL48617A0 (en) |
LU (1) | LU73997A1 (en) |
NL (1) | NL166015C (en) |
NO (1) | NO754195L (en) |
NZ (1) | NZ179502A (en) |
SE (1) | SE7513602L (en) |
ZA (1) | ZA747723B (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5486540A (en) * | 1993-10-28 | 1996-01-23 | Allergan, Inc. | Cyclopentane heptanoic or heptenoic acid, 2-arylalkyl or arylalkenyl and derivatives as therapeutic agents |
EP1114816A4 (en) * | 1998-09-14 | 2002-09-04 | Ono Pharmaceutical Co | $g(v)-SUBSTITUTED PHENYL-PROSTAGLANDIN E DERIVATIVES AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT |
CA2632653C (en) * | 2005-12-07 | 2014-11-04 | Ramot At Tel Aviv University Ltd. | Chemical derivatives of jasmonate, pharmaceutical compositions and methods of use thereof in the treatment of cancer |
US9284274B2 (en) | 2005-12-07 | 2016-03-15 | Ramot At Tel-Aviv University Ltd. | Chemical derivatives of jasmonate, pharmaceutical compositions and methods of use thereof |
US9284252B2 (en) | 2009-06-09 | 2016-03-15 | Sepal Pharma Ltd. | Use of jasmonate ester derivatives for treating benign hyperproliferative skin disorders |
PT3175852T (en) | 2012-07-19 | 2019-06-04 | Cayman Chemical Co Inc | Difluorolactam compositions for ep4-mediated osteo related diseases and conditions |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NO143741C (en) * | 1972-07-13 | 1981-04-08 | Pfizer | ANALOGY PROCEDURE FOR THE PREPARATION OF PHYSIOLOGICALLY ACTIVE PROSTAGLAND CONNECTIONS OF THE E AND F SERIES |
-
1974
- 1974-12-04 ZA ZA747723A patent/ZA747723B/en unknown
-
1975
- 1975-11-11 GR GR49337A patent/GR60310B/en unknown
- 1975-12-02 SE SE7513602A patent/SE7513602L/en unknown
- 1975-12-03 IE IE2635/75A patent/IE43815B1/en unknown
- 1975-12-08 IL IL48617A patent/IL48617A0/en unknown
- 1975-12-09 DE DE19752555210 patent/DE2555210A1/en active Pending
- 1975-12-10 DK DK559975A patent/DK559975A/en not_active Application Discontinuation
- 1975-12-10 GB GB50700/75A patent/GB1508168A/en not_active Expired
- 1975-12-10 GB GB29061/77A patent/GB1508170A/en not_active Expired
- 1975-12-10 NZ NZ179502A patent/NZ179502A/en unknown
- 1975-12-10 GB GB29060/77A patent/GB1508169A/en not_active Expired
- 1975-12-10 NO NO754195A patent/NO754195L/no unknown
- 1975-12-10 FI FI753475A patent/FI753475A/fi not_active Application Discontinuation
- 1975-12-11 ES ES443421A patent/ES443421A1/en not_active Expired
- 1975-12-11 LU LU73997A patent/LU73997A1/xx unknown
- 1975-12-11 DD DD7500197925A patent/DD129783A5/en unknown
- 1975-12-11 AT AT941675A patent/AT351185B/en not_active IP Right Cessation
- 1975-12-11 BE BE1007076A patent/BE836564A/en not_active IP Right Cessation
- 1975-12-11 JP JP50148319A patent/JPS51125257A/en active Pending
- 1975-12-11 FR FR7537944A patent/FR2293923A1/en active Granted
- 1975-12-11 NL NL7514446.A patent/NL166015C/en not_active IP Right Cessation
- 1975-12-11 CS CS758428A patent/CS194733B2/en unknown
- 1975-12-11 BG BG031757A patent/BG27227A3/en unknown
- 1975-12-11 CS CS771242A patent/CS194746B2/en unknown
- 1975-12-11 DD DD190054A patent/DD125828A5/xx unknown
- 1975-12-11 CS CS771241A patent/CS194745B2/en unknown
- 1975-12-11 DD DD7500197926A patent/DD129649A5/en unknown
- 1975-12-11 CH CH1610875A patent/CH610302A5/en not_active IP Right Cessation
-
1977
- 1977-03-11 JP JP2687577A patent/JPS52102258A/en active Pending
- 1977-03-11 JP JP2687477A patent/JPS52102270A/en active Pending
-
1979
- 1979-03-13 IL IL56863A patent/IL56863A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
ZA747723B (en) | 1976-11-24 |
ATA941675A (en) | 1978-12-15 |
JPS52102270A (en) | 1977-08-27 |
IL56863A0 (en) | 1979-05-31 |
NL166015C (en) | 1981-06-15 |
NL7514446A (en) | 1976-06-15 |
JPS52102258A (en) | 1977-08-27 |
CS194746B2 (en) | 1979-12-31 |
FI753475A (en) | 1976-06-12 |
NL166015B (en) | 1981-01-15 |
FR2293923B1 (en) | 1979-02-23 |
IE43815L (en) | 1976-06-11 |
CS194745B2 (en) | 1979-12-31 |
CH610302A5 (en) | 1979-04-12 |
IE43815B1 (en) | 1981-06-03 |
FR2293923A1 (en) | 1976-07-09 |
LU73997A1 (en) | 1976-11-11 |
IL48617A0 (en) | 1976-02-29 |
DE2555210A1 (en) | 1976-06-16 |
JPS51125257A (en) | 1976-11-01 |
BE836564A (en) | 1976-06-11 |
CS194733B2 (en) | 1979-12-31 |
GB1508170A (en) | 1978-04-19 |
NO754195L (en) | 1976-06-14 |
DD129649A5 (en) | 1978-02-01 |
AT351185B (en) | 1979-07-10 |
GR60310B (en) | 1978-05-08 |
BG27227A3 (en) | 1979-09-14 |
DK559975A (en) | 1976-06-12 |
GB1508168A (en) | 1978-04-19 |
GB1508169A (en) | 1978-04-19 |
NZ179502A (en) | 1979-01-11 |
SE7513602L (en) | 1976-06-14 |
AU8736275A (en) | 1977-10-13 |
DD125828A5 (en) | 1977-05-18 |
DD129783A5 (en) | 1978-02-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES431059A1 (en) | N-{8 (Methoxymethyl-furyl)-methyl{9 -morphinans or -6,7-benzomorphans and salts thereof | |
ES443421A1 (en) | 11-deoxy-15-substituted-16,17,18,19,20-pentanorprostaglandins | |
ES421067A1 (en) | Procedure for the preparation of new 2-phenylamine-substitute imidazolines. (Machine-translation by Google Translate, not legally binding) | |
ES403209A1 (en) | Novel acetophenone oxime derivatives | |
ES472276A1 (en) | Cis-4a-phenyl-2,3,4,4a,5,6,7,7a-octahydro-1h-2-pyrindines and pharmaceutical compositions containing them | |
ES418827A1 (en) | 2-aminoindane derivatives | |
ES404745A1 (en) | Cephalosporin compounds | |
ES419739A1 (en) | 2-aryl-amino-imidazoline-2 compounds | |
ES440153A2 (en) | Piperazinopyrimidines process for their preparation and use | |
ES435351A1 (en) | 1-(3-phenylpropyl)-4-furoylpiperazine derivatives | |
ES434405A1 (en) | Procedure for the preparation of imidazole derivatives. (Machine-translation by Google Translate, not legally binding) | |
ES438736A1 (en) | Procedure to prepare esters of dihydro-16, 17 apovincaminic acid. (Machine-translation by Google Translate, not legally binding) | |
ES440282A1 (en) | Diphenyl-butylpiperidines | |
ES465346A1 (en) | 2h-imidazole-2-thione derivatives | |
ES412047A1 (en) | Preparation of dihydrocoumarin and of alkyl derivatives thereof | |
ES437041A1 (en) | A procedure for preparing 1-ftalazone derivatives. (Machine-translation by Google Translate, not legally binding) | |
ES411184A1 (en) | Alpha-carboxy-2-thienylmethylpenicillin and cephalosporin and esters and salts thereof | |
JPS5278888A (en) | Synthesis of novel quinazoline derivatives | |
ES469913A1 (en) | 6,11-dihydrodibenzo-(b. e.)-thiepin-11-one-3-aldehyde and 3-acetal derivatives | |
ES414805A1 (en) | [NOVEL] ESTERS OF alpha-CARBOXYBENZYLPENCILLIN | |
JPS5262295A (en) | Preparation of n1-oxy-2-thioadenosines | |
ES422343A1 (en) | A procedure for preparing 3-substitute methyl-2 or 3-cefem-4- carboxylic acids. (Machine-translation by Google Translate, not legally binding) | |
ES478656A1 (en) | Procedure for preparing isoindoline derivatives. (Machine-translation by Google Translate, not legally binding) | |
ES445255A1 (en) | A procedure for the preparation of 3-substitute methyl-2 or 3cefem-4-carboxylic acids. (Machine-translation by Google Translate, not legally binding) | |
JPS5271484A (en) | Synthesis of novel quinazoline derivatives |